Project Grant R01HL169973
Award Date
9/1/24
Completion Date
6/30/28
Dollars Obligated
$2M
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Hanover, NH 03755, USA
Similar Awards
This $105,076 Project Grant was awarded on December 20, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855). The grant supports research conducted by Trustees of Dartmouth College to investigate the dual function of the TSIT immunity protein in regulating Pseudomonas aeruginosa biofilm production, which is a key challenge in treating chronic respiratory infections in cystic fibrosis...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $629,319 to Emory University to investigate methods for overcoming refractory cystic fibrosis (CF) defects. The research aims to identify cellular targets that can ameliorate disease by correcting basic defects resulting from premature termination codons (PTCs) in the CF transmembrane conductance regulator (CFTR) gene. Key research activities include...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $442,024 to Trustees of Dartmouth College to conduct research on the cellular mechanisms driving antibody effector functions. The research aims to elucidate the complex relationships between antigens, antibodies, and effector cells in order to establish design criteria for engineering antibody therapeutics with predictable and robust effector...
This federal Project Grant award of $730,494, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research), supports research to investigate the mechanisms linking the cystic fibrosis transmembrane conductance regulator (CFTR) protein to dysregulated barrier function, insulin receptor function, and glucose transport in the lungs of cystic fibrosis (CF) patients. The research aims to determine how the expression of mutant CFTR alters tight junction...
This federal Project Grant award, totaling $756,875.00, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Cincinnati. The award supports research to investigate the fundamental mechanisms by which neutrophil extracellular traps (NETs) contribute to airway damage and infection in mucoobstructive lung diseases, such as cystic fibrosis. Key research aims include examining how NET-mediated...
This $151,040 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the regulatory role of the small regulatory RNA BECO on essential virulence factors in the pathogen Pseudomonas aeruginosa. The research aims to determine how BECO controls the expression of the Type III Secretion System and pyochelin biosynthesis genes, which are critical for P....
This federal Project Grant award for $177,721.00 was provided by the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program. The award recipient is Brigham & Women's Hospital Inc., a prominent academic medical center and research institution in Boston, Massachusetts. The grant supports a research project led by Principal Investigator Nicole Prince, PhD, a biochemist with expertise in molecular epidemiology. The project aims to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,831,848 to the University of Rochester to investigate how neonatal microbiome colonization impacts lung immunity and regeneration. The research aims to elucidate how early-life microbial dysbiosis remodels the developmental program in lung-resident lymphocytes and epithelial cells, contributing to chronic respiratory disease. Key...
This Project Grant award of $759,983 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to the University of North Carolina at Chapel Hill supports research examining the diverse responses of neutrophils during Streptococcus pneumoniae pneumonia and acute lung injury. The research aims to determine changes in neutrophil transcriptomes and the lung microenvironment during the development and resolution of S. pneumoniae-induced inflammation and...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $1,061,189 to the Regents of the University of Michigan to conduct research on immune crosstalk in lung injury and fibrosis. The key objectives are to study epithelial cell regulation of fibrosis and its interaction with myeloid cells, uncover mechanisms for impaired innate immunity against gram-positive infections in fibrosis, test delivery of targeted therapeutics...